• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Statin protects the heart against ischemia-reperfusion injury via inhibition of the NLRP3 inflammasome.

作者信息

Yu Si-Yang, Tang Liang, Zhao Guo-Jun, Zhou Sheng-Hua

机构信息

Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.

Department of Histology and Embryology, Guilin Medical University, Guilin, Guangxi 541000, China.

出版信息

Int J Cardiol. 2017 Feb 15;229:23-24. doi: 10.1016/j.ijcard.2016.11.219. Epub 2016 Nov 9.

DOI:10.1016/j.ijcard.2016.11.219
PMID:27865664
Abstract
摘要

相似文献

1
Statin protects the heart against ischemia-reperfusion injury via inhibition of the NLRP3 inflammasome.他汀类药物通过抑制NLRP3炎性小体保护心脏免受缺血再灌注损伤。
Int J Cardiol. 2017 Feb 15;229:23-24. doi: 10.1016/j.ijcard.2016.11.219. Epub 2016 Nov 9.
2
Ghrelin protects the heart against ischemia/reperfusion injury via inhibition of TLR4/NLRP3 inflammasome pathway.生长激素释放肽通过抑制 TLR4/NLRP3 炎性小体通路保护心脏免受缺血/再灌注损伤。
Life Sci. 2017 Oct 1;186:50-58. doi: 10.1016/j.lfs.2017.08.004. Epub 2017 Aug 4.
3
Pharmacological Inhibition of NLRP3 Inflammasome Attenuates Myocardial Ischemia/Reperfusion Injury by Activation of RISK and Mitochondrial Pathways.NLRP3炎性小体的药理学抑制通过激活RISK和线粒体途径减轻心肌缺血/再灌注损伤
Oxid Med Cell Longev. 2016;2016:5271251. doi: 10.1155/2016/5271251. Epub 2016 Dec 8.
4
Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia-reperfusion in the mouse.抑制NLRP3炎性小体可限制小鼠心肌缺血再灌注后的炎症损伤。
Int J Cardiol. 2016 Apr 15;209:215-20. doi: 10.1016/j.ijcard.2016.02.043. Epub 2016 Feb 4.
5
TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury.TXNIP作为心肌缺血/再灌注损伤的一种新机制，介导心脏微血管内皮细胞中NLRP3炎性小体的激活。
Basic Res Cardiol. 2014;109(5):415. doi: 10.1007/s00395-014-0415-z. Epub 2014 Jul 12.
6
The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury.NLRP3 炎性体在心肌成纤维细胞中上调，并介导心肌缺血再灌注损伤。
Cardiovasc Res. 2013 Jul 1;99(1):164-74. doi: 10.1093/cvr/cvt091. Epub 2013 Apr 10.
7
Maladaptive Modulations of NLRP3 Inflammasome and Cardioprotective Pathways Are Involved in Diet-Induced Exacerbation of Myocardial Ischemia/Reperfusion Injury in Mice.NLRP3炎性小体和心脏保护通路的适应性调节异常参与饮食诱导的小鼠心肌缺血/再灌注损伤的加重。
Oxid Med Cell Longev. 2016;2016:3480637. doi: 10.1155/2016/3480637. Epub 2015 Dec 14.
8
The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and Preserves Contractile Function After Ischemia Reperfusion Injury in the Mouse.NLRP3 炎性小体抑制剂 OLT1177（达帕那肽）可减少小鼠缺血再灌注损伤后的梗死面积并维持收缩功能。
J Cardiovasc Pharmacol. 2019 Apr;73(4):215-222. doi: 10.1097/FJC.0000000000000658.
9
Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine.替格瑞洛和瑞舒伐他汀通过腺苷具有相加的心脏保护作用。
Cardiovasc Drugs Ther. 2016 Dec;30(6):539-550. doi: 10.1007/s10557-016-6701-2.
10
Statin and myocardial ischemia-reperfusion injury.
Int J Cardiol. 2016 Nov 1;222:988. doi: 10.1016/j.ijcard.2016.08.143. Epub 2016 Aug 8.

引用本文的文献

1
Treatment mechanism of immune triad from the repurposing drug against COVID-19.新冠病毒老药新用之免疫三联征的治疗机制
Transl Med Aging. 2023;7:33-45. doi: 10.1016/j.tma.2023.06.005. Epub 2023 Jun 24.
2
Gypensapogenin I Ameliorates Isoproterenol (ISO)-Induced Myocardial Damage through Regulating the TLR4/NF-κB/NLRP3 Pathway.吉普萨烯醇 I 通过调控 TLR4/NF-κB/NLRP3 通路减轻异丙肾上腺素（ISO）诱导的心肌损伤。
Molecules. 2022 Aug 19;27(16):5298. doi: 10.3390/molecules27165298.
3
NLRP3 inflammasome as a novel therapeutic target for heart failure.
NLRP3 炎性小体作为心力衰竭的一个新的治疗靶点。
Anatol J Cardiol. 2022 Jan;26(1):15-22. doi: 10.5152/AnatolJCardiol.2021.580.
4
NLRP3 Inflammasome and Its Central Role in the Cardiovascular Diseases.NLRP3 炎性小体及其在心血管疾病中的核心作用。
Oxid Med Cell Longev. 2020 Apr 14;2020:4293206. doi: 10.1155/2020/4293206. eCollection 2020.
5
Regulatory Mechanisms of the NLRP3 Inflammasome, a Novel Immune-Inflammatory Marker in Cardiovascular Diseases.NLRP3 炎性小体的调控机制：心血管疾病中新型免疫炎症标志物。
Front Immunol. 2019 Jul 10;10:1592. doi: 10.3389/fimmu.2019.01592. eCollection 2019.
6
NLRP3 inflammasome activation from Kupffer cells is involved in liver fibrosis of Schistosoma japonicum-infected mice via NF-κB.Kupffer 细胞中的 NLRP3 炎性小体激活通过 NF-κB 参与日本血吸虫感染小鼠的肝纤维化。
Parasit Vectors. 2019 Jan 11;12(1):29. doi: 10.1186/s13071-018-3223-8.
7
Functional Implications of HMG-CoA Reductase Inhibition on Glucose Metabolism.HMG-CoA还原酶抑制对葡萄糖代谢的功能影响
Korean Circ J. 2018 Nov;48(11):951-963. doi: 10.4070/kcj.2018.0307.
8
NLRP3: A Novel Mediator in Cardiovascular Disease.NLRP3：心血管疾病的新介质。
J Immunol Res. 2018 Apr 8;2018:5702103. doi: 10.1155/2018/5702103. eCollection 2018.
9
NLRP3 inflammasome activation results in liver inflammation and fibrosis in mice infected with Schistosoma japonicum in a Syk-dependent manner.NLRP3 炎性小体的激活导致感染日本血吸虫的小鼠肝脏炎症和纤维化，这种作用依赖于 Syk。
Sci Rep. 2017 Aug 14;7(1):8120. doi: 10.1038/s41598-017-08689-1.